ArticlePaediatric drugs2026

Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple Sclerosis.

Vivien X Xie Cherng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.